Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis
Autor: | Yoshiyuki Ogawa, Takuya Araki, Tetsuya Shigehara, Daisuke Nagano, Kazuhisa Saruki, Yoshihisa Nojima, Hiroshi Handa, Kunio Yanagisawa, Koujirou Yamamoto, Hideki Uchiumi |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Oncology medicine.medical_specialty business.industry medicine.medical_treatment 030106 microbiology Immunology Treatment outcome 030232 urology & nephrology Raltegravir Raltegravir Potassium 03 medical and health sciences 0302 clinical medicine Infectious Diseases Pharmacokinetics Internal medicine medicine Immunology and Allergy Hiv infected patients Hemodialysis Viral suppression business medicine.drug |
Zdroj: | AIDS. 30:970-972 |
ISSN: | 0269-9370 |
Databáze: | OpenAIRE |
Externí odkaz: |